Skip to main content
Caplight Logo









PharmAssess Diagnostics Corp.

PharmAssess Diagnostics Corp.

Private
TorontoHealthcare & Life Scienceshttps://pharmassess.ca/

Last Round

Grant

Jan 1, 2021

Total Funding Raised

$8,500

Company Overview

PharmAssess Diagnostics Corp. operates in Healthcare & Life Sciences and is based in Toronto. Its latest recorded funding round was a Grant round in January 2021.

PharmAssess Diagnostics Corp. is a health technology company that provides diagnostic software solutions to assist pharmacists in the assessment, treatment, and documentation of minor ailments.

Sector

Healthcare & Life Sciences

Verticals

Vertical SaaS, Workflow Automation, Patient Engagement

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

PharmAssess Diagnostics Corp. Comparables

Compare PharmAssess Diagnostics Corp. with similar companies based on industry and business-model similarity.

PharmAssess Diagnostics Corp. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MAPflow
94%
RPhNote
89%
MedMe
89%
Book a demo to see all comparables

For institutional investors. Book with your work email.

PharmAssess Diagnostics Corp. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 1, 2021
AcceleratorAug 6, 2020
GrantMar 1, 2019
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

PharmAssess Diagnostics Corp. Investors

Notable investors and investment history

PharmAssess Diagnostics Corp. investors
InvestorRounds
gener8torAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 11, 2026

    Monthly visitors increased 95% MoM, reaching 6.4K.

  • Jan 1, 2021

    $4.7K grant round completed.

Book a demo to see all signals

For institutional investors. Book with your work email.

PharmAssess Diagnostics Corp. Filings

Explore SEC and related filing metadata, where available.

PharmAssess Diagnostics Corp. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about PharmAssess Diagnostics Corp.'s valuation, stock price, and market status.

Is PharmAssess Diagnostics Corp. a public or private company?

PharmAssess Diagnostics Corp. is a private company.

What is the current stock price of PharmAssess Diagnostics Corp.?

PharmAssess Diagnostics Corp. is a private company, so its shares have no public market price. Caplight tracks PharmAssess Diagnostics Corp.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is PharmAssess Diagnostics Corp. worth (valuation)?

Valuation information for PharmAssess Diagnostics Corp. is not publicly available.

Can I buy PharmAssess Diagnostics Corp. stock?

PharmAssess Diagnostics Corp. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was PharmAssess Diagnostics Corp.'s last funding round?

PharmAssess Diagnostics Corp.'s most recent funding round was Grant on January 1, 2021.

Who are the main investors in PharmAssess Diagnostics Corp.?

Key investors in PharmAssess Diagnostics Corp. include gener8tor.

Will PharmAssess Diagnostics Corp. IPO soon?

No public IPO plans have been announced for PharmAssess Diagnostics Corp..

How can I track PharmAssess Diagnostics Corp. secondary market activity?

Caplight tracks bids, offers, and trades in PharmAssess Diagnostics Corp.'s shares on secondary markets.

Firmographic Details

HeadquartersToronto
Employee Range3
Year Founded2020
Last FundingJan 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?